The University of Pittsburgh recently obtained a Department of Health and Human Services (HHS) grant to assess the problem of hospital patients dying from sepsis, which might be preventable through a standardized treatment policy.
Asbury Heights, home to 500 seniors and provider of a range of care options, recently became affiliated with University of Pittsburgh Medical Center (UPMC) Senior Communities, enhancing accessibility to resources for residents and staff.
Eli Lilly and Company representatives recently presented Phase 3 study results for the advanced urothelial carcinoma treatment Cyramza (ramucirumab) at an international summit, stating that data indicate improved survival chances in those patients treated with ramucirumab and docetaxel.
House Ways and Means Committee Chairman Kevin Brady (R-TX) gave the opening statement for a recent Washington, D.C.-based legislation markup session convened for the purpose of improving Medicare options and increasing welfare solutions.
Massachusetts-based Alnylam Pharmaceuticals, an affiliate of health care solution developer Sanofi currently taking a lead role in a clinical development program addressing hemophilia, recently revealed an adverse event in relation to its investigational treatment fitusiran.
GlaxoSmithKline (GSK) said its Shingrix vaccine, indicated for the prevention of herpes zoster (commonly known as shingles) in older adults, recently attained unanimous preliminary approval from a U.S. Food and Drug Administration (FDA) advisory committee.
Europe is struggling when it comes to advanced data use for health care purposes and innovative initiatives are needed for the region to become a leader in establishing patient-health professional networks, a guest blog posted on the Lilly in Europe website said.
With September being Newborn Screening Awareness Month, a nonprofit group is encouraging greater public awareness of the importance of testing infants for certain diseases at birth and is planning a free online educational seminar on Oct. 4.
Social determinants of health – the conditions in which people live, work and age – and how they impact the quality and price of health care was the focus of a recent congressional briefing involving several health industry representatives.
Sanofi and Regeneron Pharmaceuticals recently reported positive outcomes from a joint Phase 3 study of Dupixent (dupilumab) in addressing symptoms of moderate-to-severe atopic dermatitis, a form of eczema that presents as red, itchy skin and rashes.